{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:03:03Z","timestamp":1789401783772,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FPU 22\/02476"],"award-info":[{"award-number":["FPU 22\/02476"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-137399OB-I00"],"award-info":[{"award-number":["PID2022-137399OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FPU 21\/02594"],"award-info":[{"award-number":["FPU 21\/02594"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["K23MH129882"],"award-info":[{"award-number":["K23MH129882"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG083874"],"award-info":[{"award-number":["R01 AG083874"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24AG082930"],"award-info":[{"award-number":["U24AG082930"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG066468"],"award-info":[{"award-number":["P30 AG066468"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 AG077474"],"award-info":[{"award-number":["RF1 AG077474"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG083156"],"award-info":[{"award-number":["R01 AG083156"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37 AG023651"],"award-info":[{"award-number":["R37 AG023651"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG025516"],"award-info":[{"award-number":["R01 AG025516"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG073267"],"award-info":[{"award-number":["R01 AG073267"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG075336"],"award-info":[{"award-number":["R01 AG075336"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG072641"],"award-info":[{"award-number":["R01 AG072641"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AG025204"],"award-info":[{"award-number":["P01 AG025204"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 NS131740"],"award-info":[{"award-number":["U01 NS131740"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 NS141777"],"award-info":[{"award-number":["U01 NS141777"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH108509"],"award-info":[{"award-number":["R01 MH108509"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aging Mind Foundation","award":["DAF2255207"],"award-info":[{"award-number":["DAF2255207"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-01967-1","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T07:15:14Z","timestamp":1762413314000},"page":"5695-5708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Classification accuracies of plasma ptau217 vs. ptau217\/A\u03b21-42 for brain A\u03b2 pathology in cognitively normal older adults"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7922-1647","authenticated-orcid":false,"given":"Marcos","family":"Olvera-Rojas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Solis-Urra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Fernandez-Gamez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Coca-Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Trivi\u00f1o-Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Oberlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Domingo","family":"Gispert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk I.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"G\u00f3mez-R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Karikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco B.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Esteban-Cornejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"1967_CR1","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","volume":"81","author":"B Dubois","year":"2024","unstructured":"Dubois B, Villain N, Schneider L, Fox N, Campbell N, Galasko D, et al. Alzheimer disease as a clinical-biological construct\u2014an international working group recommendation. JAMA Neurol. 2024;81:1304. https:\/\/doi.org\/10.1001\/jamaneurol.2024.3770.","journal-title":"JAMA Neurol"},{"key":"1967_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vhri.2023.09.008","volume":"40","author":"LX Tay","year":"2024","unstructured":"Tay LX, Ong SC, Tay LJ, Ng T, Parumasivam T. Economic burden of Alzheimer\u2019s disease: a systematic review. Value Health Reg Issues. 2024;40:1\u201312. https:\/\/doi.org\/10.1016\/j.vhri.2023.09.008.","journal-title":"Value Health Reg Issues"},{"key":"1967_CR3","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack","year":"2024","unstructured":"Jack CR, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association workgroup. Alzheimers Dement. 2024;20:5143\u201369. https:\/\/doi.org\/10.1002\/alz.13859.","journal-title":"Alzheimers Dement"},{"key":"1967_CR4","doi-asserted-by":"publisher","unstructured":"Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA, et al. High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology 2019;93. https:\/\/doi.org\/10.1212\/WNL.0000000000008081.","DOI":"10.1212\/WNL.0000000000008081"},{"key":"1967_CR5","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1038\/s41467-024-47286-5","volume":"15","author":"F Gonzalez-Ortiz","year":"2024","unstructured":"Gonzalez-Ortiz F, Kirsebom B-E, Contador J, Tanley JE, Selnes P, G\u00edslad\u00f3ttir B, et al. Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer\u2019s disease. Nat Commun. 2024;15:2908. https:\/\/doi.org\/10.1038\/s41467-024-47286-5.","journal-title":"Nat Commun"},{"key":"1967_CR6","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","volume":"29","author":"B Bellaver","year":"2023","unstructured":"Bellaver B, Povala G, Ferreira PCL, Ferrari-Souza JP, Leffa DT, Lussier FZ, et al. Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer\u2019s disease. Nat Med. 2023;29:1775\u201381. https:\/\/doi.org\/10.1038\/s41591-023-02380-x.","journal-title":"Nat Med"},{"key":"1967_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01593-7","volume":"16","author":"K G\u00f6tze","year":"2024","unstructured":"G\u00f6tze K, Vrillon A, Dumurgier J, Indart S, Sanchez-Ortiz M, Slimi H, et al. Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study. Alzheimers Res Ther. 2024;16:231. https:\/\/doi.org\/10.1186\/s13195-024-01593-7.","journal-title":"Alzheimers Res Ther"},{"key":"1967_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19:422\u201333. https:\/\/doi.org\/10.1016\/S1474-4422(20)30071-5.","journal-title":"Lancet Neurol"},{"key":"1967_CR9","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114022","author":"N Mattsson-Carlgren","year":"2021","unstructured":"Mattsson-Carlgren N, Janelidze S, Bateman RJ, Smith R, Stomrud E, Serrano GE, et al. Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau. EMBO Mol Med. 2021. https:\/\/doi.org\/10.15252\/emmm.202114022.","journal-title":"EMBO Mol Med"},{"key":"1967_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14430","author":"M Olvera-Rojas","year":"2025","unstructured":"Olvera-Rojas M, Sewell KR, Karikari TK, Huang H, Oberlin LE, Zeng X, et al. Influence of medical conditions on the diagnostic accuracy of plasma p-tau217 and p-tau217\/A\u03b242. Alzheimers Dement. 2025. https:\/\/doi.org\/10.1002\/alz.14430.","journal-title":"Alzheimers Dement"},{"key":"1967_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105805","volume":"117","author":"S Lehmann","year":"2025","unstructured":"Lehmann S, Gabelle A, Duchiron M, Busto G, Morchikh M, Delaby C, et al. Comparative performance of plasma pTau181\/A\u03b242, pTau217\/A\u03b242 ratios, and individual measurements in detecting brain amyloidosis. EBioMedicine. 2025;117:105805. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105805.","journal-title":"EBioMedicine"},{"key":"1967_CR12","doi-asserted-by":"publisher","DOI":"10.5582\/ddt.2025.01055","volume":"19","author":"S Hu","year":"2025","unstructured":"Hu S, Yu H, Gao J. The pTau217\/A\u03b21-42 plasma ratio: the first FDA-cleared blood biomarker test for diagnosis of Alzheimer\u2019s disease. Drug Discov Ther. 2025;19:2025.01055. https:\/\/doi.org\/10.5582\/ddt.2025.01055.","journal-title":"Drug Discov Ther"},{"key":"1967_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.1100","author":"A Pichet Binette","year":"2025","unstructured":"Pichet Binette A, Smith R, Salvad\u00f3 G, Tideman P, Glans I, van Westen D, et al. Evaluation of the revised criteria for biological and clinical staging of Alzheimer disease. JAMA Neurol. 2025. https:\/\/doi.org\/10.1001\/jamaneurol.2025.1100.","journal-title":"JAMA Neurol"},{"key":"1967_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14619","author":"KR Sewell","year":"2025","unstructured":"Sewell KR, Oberlin LE, Karikari TK, Olvera-Rojas M, Wan L, Morris JK, et al. Blood biomarkers differentiate AD-related versus non-AD-related cognitive deficits. Alzheimers Dement. 2025. https:\/\/doi.org\/10.1002\/alz.14619.","journal-title":"Alzheimers Dement"},{"key":"1967_CR15","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/alz.12787","volume":"19","author":"A Pichet Binette","year":"2023","unstructured":"Pichet Binette A, Janelidze S, Cullen N, Dage JL, Bateman RJ, Zetterberg H, et al. Confounding factors of Alzheimer\u2019s disease plasma biomarkers and their impact on clinical performance. Alzheimers Dement. 2023;19:1403\u201314. https:\/\/doi.org\/10.1002\/alz.12787.","journal-title":"Alzheimers Dement"},{"key":"1967_CR16","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/alz.12466","volume":"18","author":"JA Syrjanen","year":"2022","unstructured":"Syrjanen JA, Campbell MR, Algeciras-Schimnich A, Vemuri P, Graff-Radford J, Machulda MM, et al. Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities. Alzheimers Dement. 2022;18:1128\u201340. https:\/\/doi.org\/10.1002\/alz.12466.","journal-title":"Alzheimers Dement"},{"key":"1967_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70096","author":"C Chen","year":"2025","unstructured":"Chen C, Zhang M, Wang Z, Deng J, Bao Y, Shi J, et al. Associations among sleep quality, sleep duration, and Alzheimer\u2019s disease biomarkers: a systematic review and meta-analysis. Alzheimers Dement. 2025. https:\/\/doi.org\/10.1002\/alz.70096.","journal-title":"Alzheimers Dement"},{"key":"1967_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2023.1168549","author":"P Solis-Urra","year":"2023","unstructured":"Solis-Urra P, Molina-Hidalgo C, Garc\u00eda-Rivero Y, Costa-Rodriguez C, Mora-Gonzalez J, Fernandez-Gamez B, et al. Active gains in brain using exercise during aging (AGUEDA): protocol for a randomized controlled trial. Front Hum Neurosci. 2023. https:\/\/doi.org\/10.3389\/fnhum.2023.1168549.","journal-title":"Front Hum Neurosci"},{"key":"1967_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2188\/jea.JE20110003","volume":"21","author":"K Tomioka","year":"2011","unstructured":"Tomioka K, Iwamoto J, Saeki K, Okamoto N. Reliability and validity of the International Physical Activity Questionnaire (IPAQ) in elderly adults: the Fujiwara-kyo study. J Epidemiol. 2011;21:459\u201365. https:\/\/doi.org\/10.2188\/jea.JE20110003.","journal-title":"J Epidemiol"},{"key":"1967_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.gaceta.2018.05.004","volume":"33","author":"M Mu\u00f1oz-Garc\u00eda","year":"2019","unstructured":"Mu\u00f1oz-Garc\u00eda M, Cervantes S, Razquin C, Guill\u00e9n-Grima F, Toledo JB, Mart\u00ednez-Gonz\u00e1lez M\u00c1, et al. Validation study of a Spanish version of the modified telephone interview for cognitive status (STICS-m). Gac Sanit. 2019;33:415\u201320. https:\/\/doi.org\/10.1016\/j.gaceta.2018.05.004.","journal-title":"Gac Sanit"},{"key":"1967_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1076\/anec.11.1.1.29366","volume":"11","author":"SR de Beaman","year":"2004","unstructured":"de Beaman SR, Beaman PE, Garcia-Pe\u00f1a C, Villa MA, Heres J, C\u00f3rdova A, et al. Validation of a modified version of the mini-mental state examination (MMSE) in Spanish. Aging Neuropsychol Cogn. 2004;11:1\u201311. https:\/\/doi.org\/10.1076\/anec.11.1.1.29366.","journal-title":"Aging Neuropsychol Cogn"},{"key":"1967_CR22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.33588\/rn.6311.2016241","volume":"63","author":"N Ojeda","year":"2016","unstructured":"Ojeda N, Del Pino R, Ibarretxe-Bilbao N, Schretlen DJ, Pena J. Montreal Cognitive Assessment Test: normalization and standardization for Spanish population. Rev Neurol. 2016;63:488\u201396.","journal-title":"Rev Neurol"},{"key":"1967_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/gps.588","volume":"17","author":"MI Fern\u00e1ndez-San Mart\u00edn","year":"2002","unstructured":"Fern\u00e1ndez-San Mart\u00edn MI, Andrade C, Molina J, Mu\u00f1oz PE, Carretero B, Rodr\u00edguez M, et al. Validation of the Spanish version of the geriatric depression scale (GDS) in primary care. Int J Geriatr Psychiatry. 2002;17:279\u201387. https:\/\/doi.org\/10.1002\/gps.588.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1967_CR24","doi-asserted-by":"publisher","unstructured":"Karikari T, Chen Y, Zeng X, Olvera-Rojas M, Sehrawat A, Lafferty T, et al. A streamlined, resource-efficient immunoprecipitation-mass spectrometry method for quantifying plasma amyloid-\u03b2 biomarkers in Alzheimer\u2019s disease. Res Sq 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-4947448\/v1.","DOI":"10.21203\/rs.3.rs-4947448\/v1"},{"key":"1967_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Jagust WJ, et al. The centiloid project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015;11:1. https:\/\/doi.org\/10.1016\/j.jalz.2014.07.003.","journal-title":"Alzheimers Dement"},{"key":"1967_CR26","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00259-017-3749-6","volume":"44","author":"CC Rowe","year":"2017","unstructured":"Rowe CC, Dor\u00e9 V, Jones G, Baxendale D, Mulligan RS, Bullich S, et al. 18F-florbetaben PET beta-amyloid binding expressed in centiloids. Eur J Nucl Med Mol Imaging. 2017;44:2053\u20139. https:\/\/doi.org\/10.1007\/s00259-017-3749-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1967_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0478-z","volume":"11","author":"G Salvad\u00f3","year":"2019","unstructured":"Salvad\u00f3 G, Molinuevo JL, Brugulat-Serrat A, Falcon C, Grau-Rivera O, Su\u00e1rez-Calvet M, et al. Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers. Alzheimers Res Ther. 2019;11:27. https:\/\/doi.org\/10.1186\/s13195-019-0478-z.","journal-title":"Alzheimers Res Ther"},{"key":"1967_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2018.09.001","volume":"15","author":"R La Joie","year":"2019","unstructured":"La Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, et al. Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer\u2019s disease neuropathology. Alzheimers Dement. 2019;15:205\u201316. https:\/\/doi.org\/10.1016\/j.jalz.2018.09.001.","journal-title":"Alzheimers Dement"},{"key":"1967_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-025-02051-6","author":"R Yamakuni","year":"2025","unstructured":"Yamakuni R, Abe M, Ukon N, Matsuda H, Takano H, Sawamoto N, et al. Comparison and cutoff values of two amyloid PET scaling methods: centiloid scale and amyloid-\u03b2 load. Ann Nucl Med. 2025. https:\/\/doi.org\/10.1007\/s12149-025-02051-6.","journal-title":"Ann Nucl Med"},{"key":"1967_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Neurology. 1991;41:479\u2013479. https:\/\/doi.org\/10.1212\/WNL.41.4.479.","journal-title":"Neurology"},{"key":"1967_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/sms.14746","author":"A Coca-Pulido","year":"2024","unstructured":"Coca-Pulido A, Solis-Urra P, Fernandez-Gamez B, Olvera-Rojas M, Bell\u00f3n D, Sclafani A, et al. Fitness, gray matter volume, and executive function in cognitively normal older adults: cross-sectional findings from the AGUEDA trial. Scand J Med Sci Sports. 2024. https:\/\/doi.org\/10.1111\/sms.14746.","journal-title":"Scand J Med Sci Sports"},{"key":"1967_CR32","doi-asserted-by":"publisher","unstructured":"Fernandez-Gamez B, Solis-Urra P, Coca-Pulido A, Molina-Hidalgo C, Olvera-Rojas M, A. Bakker E, et al. Effect of a 24-week resistance exercise intervention on cognitive function in cognitively normal older adults: The AGUEDA Randomized Controlled Trial 2025. https:\/\/doi.org\/10.1101\/2025.04.29.25326693.","DOI":"10.1101\/2025.04.29.25326693"},{"key":"1967_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/bjsports-2024-108257","volume":"59","author":"LE Oberlin","year":"2025","unstructured":"Oberlin LE, Wan L, Kang C, Romano A, Aghjayan S, Lesnovskaya A, et al. Cardiorespiratory fitness is associated with cognitive function in late adulthood: baseline findings from the IGNITE study. Br J Sports Med. 2025;59:167\u201376. https:\/\/doi.org\/10.1136\/bjsports-2024-108257.","journal-title":"Br J Sports Med"},{"key":"1967_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193\u2013213. https:\/\/doi.org\/10.1016\/0165-1781(89)90047-4.","journal-title":"Psychiatry Res"},{"key":"1967_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E, et al. Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol. 2024;81:255. https:\/\/doi.org\/10.1001\/jamaneurol.2023.5319.","journal-title":"JAMA Neurol"},{"key":"1967_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/alz.12395","volume":"18","author":"S Janelidze","year":"2022","unstructured":"Janelidze S, Palmqvist S, Leuzy A, Stomrud E, Verberk IMW, Zetterberg H, et al. Detecting amyloid positivity in early Alzheimer\u2019s disease using combinations of plasma A\u03b242\/A\u03b240 and p-tau. Alzheimers Dement. 2022;18:283\u201393. https:\/\/doi.org\/10.1002\/alz.12395.","journal-title":"Alzheimers Dement"},{"key":"1967_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-024-00977-5","author":"SE Schindler","year":"2024","unstructured":"Schindler SE, Galasko D, Pereira AC, Rabinovici GD, Salloway S, Su\u00e1rez-Calvet M, et al. Acceptable performance of blood biomarker tests of amyloid pathology \u2014 recommendations from the Global CEO Initiative on Alzheimer\u2019s Disease. Nat Rev Neurol. 2024. https:\/\/doi.org\/10.1038\/s41582-024-00977-5.","journal-title":"Nat Rev Neurol"},{"key":"1967_CR38","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s43587-023-00471-5","volume":"3","author":"WS Brum","year":"2023","unstructured":"Brum WS, Cullen NC, Janelidze S, Ashton NJ, Zimmer ER, Therriault J, et al. A two-step workflow based on plasma p-tau217 to screen for amyloid \u03b2 positivity with further confirmatory testing only in uncertain cases. Nat Aging. 2023;3:1079\u201390. https:\/\/doi.org\/10.1038\/s43587-023-00471-5.","journal-title":"Nat Aging"},{"key":"1967_CR39","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/WAD.0b013e3181a6bebc","volume":"23","author":"A Bradford","year":"2009","unstructured":"Bradford A, Kunik ME, Schulz P, Williams SP, Singh H. Missed and delayed diagnosis of dementia in primary care. Alzheimer Dis Assoc Disord. 2009;23:306\u201314. https:\/\/doi.org\/10.1097\/WAD.0b013e3181a6bebc.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1967_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.arr.2015.08.006","volume":"24","author":"D Tromp","year":"2015","unstructured":"Tromp D, Dufour A, Lithfous S, Pebayle T, Despr\u00e9s O. Episodic memory in normal aging and Alzheimer disease: insights from imaging and behavioral studies. Ageing Res Rev. 2015;24:232\u201362. https:\/\/doi.org\/10.1016\/j.arr.2015.08.006.","journal-title":"Ageing Res Rev"},{"key":"1967_CR41","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jalz.2019.09.085","volume":"16","author":"RJ Caselli","year":"2020","unstructured":"Caselli RJ, Langlais BT, Dueck AC, Chen Y, Su Y, Locke DEC, et al. Neuropsychological decline up to 20 years before incident mild cognitive impairment. Alzheimers Dement. 2020;16:512\u201323. https:\/\/doi.org\/10.1016\/j.jalz.2019.09.085.","journal-title":"Alzheimers Dement"},{"key":"1967_CR42","doi-asserted-by":"publisher","unstructured":"Li X, Song R, Qi X, Xu H, Yang W, Kivipelto M, et al. Influence of Cognitive Reserve on Cognitive Trajectories. Neurology 2021;97. https:\/\/doi.org\/10.1212\/WNL.0000000000012728.","DOI":"10.1212\/WNL.0000000000012728"},{"key":"1967_CR43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/01.wad.0000213815.20177.19","volume":"20","author":"Y Stern","year":"2006","unstructured":"Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord. 2006;20:112\u20137. https:\/\/doi.org\/10.1097\/01.wad.0000213815.20177.19.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1967_CR44","doi-asserted-by":"publisher","unstructured":"Povala G, Bellaver B, Bastiani MA De, Ferrari\u2010Souza JP, Aguzzoli CS, Leffa DT, et al. Amyloid beta and tau are associated with the dual effect of neuroinflammation on neurodegeneration. Alzheimer\u2019s & Dementia 2025;21. https:\/\/doi.org\/10.1002\/alz.70746.","DOI":"10.1002\/alz.70746"},{"key":"1967_CR45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/13872877251329468","volume":"105","author":"J Labonte","year":"2025","unstructured":"Labonte J, Sugarman MA, Pettway E, Zetterberg H, Blennow K, Ashton NJ, et al. Sex differences on tau, astrocytic, and neurodegenerative plasma biomarkers. J Alzheimers Dis. 2025;105:443\u201352. https:\/\/doi.org\/10.1177\/13872877251329468.","journal-title":"J Alzheimers Dis"},{"key":"1967_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01684-z","volume":"17","author":"C Boccalini","year":"2025","unstructured":"Boccalini C, Peretti DE, Scheffler M, Mu L, Griffa A, Testart N, et al. Sex differences in the association of Alzheimer\u2019s disease biomarkers and cognition in a multicenter memory clinic study. Alzheimers Res Ther. 2025;17:46. https:\/\/doi.org\/10.1186\/s13195-025-01684-z.","journal-title":"Alzheimers Res Ther"},{"key":"1967_CR47","doi-asserted-by":"publisher","DOI":"10.1177\/1759091420949680","author":"A Messing","year":"2020","unstructured":"Messing A, Brenner M. GFAP at 50. ASN Neuro. 2020. https:\/\/doi.org\/10.1177\/1759091420949680.","journal-title":"ASN Neuro"},{"key":"1967_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100205","author":"S Abbas","year":"2025","unstructured":"Abbas S, Ferreira PCL, Bellaver B, Povala G, Rohden F, Aguzzoli CS, et al. Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2025. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100205.","journal-title":"J Prev Alzheimers Dis"},{"key":"1967_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.16226","author":"D Gogishvili","year":"2025","unstructured":"Gogishvili D, Honey MIJ, Verberk IMW, Vermunt L, Hol EM, Teunissen CE, et al. The GFAP proteoform puzzle: how to advance GFAP as a fluid biomarker in neurological diseases. J Neurochem. 2025. https:\/\/doi.org\/10.1111\/jnc.16226.","journal-title":"J Neurochem"},{"key":"1967_CR50","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1007\/s10072-022-06068-x","volume":"43","author":"R Botto","year":"2022","unstructured":"Botto R, Callai N, Cermelli A, Causarano L, Rainero I. Anxiety and depression in Alzheimer\u2019s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline. Neurol Sci. 2022;43:4107\u201324. https:\/\/doi.org\/10.1007\/s10072-022-06068-x.","journal-title":"Neurol Sci"},{"key":"1967_CR51","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.maturitas.2014.05.009","volume":"79","author":"S Bennett","year":"2014","unstructured":"Bennett S, Thomas AJ. Depression and dementia: cause, consequence or coincidence? Maturitas. 2014;79:184\u201390. https:\/\/doi.org\/10.1016\/j.maturitas.2014.05.009.","journal-title":"Maturitas"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01967-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01967-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01967-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:05:51Z","timestamp":1789398351000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01967-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1967"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01967-1","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KIE has consulted for MedRhythms, Inc. and NeoAuvra, Inc. TKK has consulted for Quanterix Corporation, SpearBio Inc., Neurogen Biomarking LLC., and Alzheon, has served on advisory boards for Siemens Healthineers, Neurogen Biomarking LLC. and Alzheon (which may come with minority stock equity interest\/stock options), outside the submitted work. He has received in-kind research support from Janssen Research Laboratories, SpearBio Inc., and Alamar Biosciences, as well as meeting travel support from the Alzheimer\u2019s Association and Neurogen Biomarking LLC., outside the submitted work. TKK has received royalties from Bioventix for the transfer of specific tau antibodies and assays to third party organizations. He has received honoraria for speaker\/grant review engagements from the NIH, UPENN, UW\u2010Madison, the Cherry Blossom symposium, the HABS-HD\/ADNI4 Health Enhancement Scientific Program, Advent Health Translational Research Institute, Brain Health conference, Barcelona\u2010Pittsburgh conference, the International Neuropsychological Society, the Icahn School of Medicine at Mount Sinai and the Quebec Center for Drug Discovery, Canada, all outside of the submitted work. TKK serves\/has served as a guest editor for npj Dementia, as an invited member of the World Health Organization committee to develop preferred product characteristics for blood-based biomarker diagnostics for Alzheimer\u2019s disease, as an executive committee member for the Human Amyloid Imaging (HAI) conference, as an elected member of the NACC ADRCs Steering Committee, as co-director of the NACC ADRCs Biofluid Biomarker Working Group, and as a member of the Alzheimer\u2019s Association committees to develop Appropriate Use Criteria for clinical use of blood-based biomarkers, and treatment related amyloid clearance. TKK is an inventor on several patents and provisional patents regarding biofluid biomarker methods, targets and reagents\/compositions, that may generate income for the institution and\/or self should they be licensed and\/or transferred to another organization. These include WO2020193500A1: Use of a ps396 assay to diagnose tauopathies; 63\/679,361: Methods to Evaluate Early-Stage Pre-Tangle TAU Aggregates and Treatment of Alzheimer\u2019s Disease Patients; 63\/672,952: Method for the Quantification of Plasma Amyloid-Beta Biomarkers in Alzheimer's Disease; 63\/693,956: Anti-tau Protein Antigen Binding Reagents; and 2450702\u20132: Detection of oligomeric tau and soluble tau aggregates. The rest of the authors have nothing to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}